Sartorius Stedim Biotech takes majority stake in AllPure Technologies

摘要

Sartorius Stedim Biotech (SSB) has agreed to take a majority stake in US start-up company AllPure Technologies, based in New Oxford, PA. No financial terms have been disclosed.AllPure, which employs 25 people, specialises in single-use components for biopharmaceutical applications, such as aseptic sampling techniques.'AllPure further completes our portfolio with innovative products that help our customers develop and manufacture their pharmaceutical drugs safely and more efficiently,' said Reinhard Vogt, a member of SSB's Executive Board.